Preventing platelet thrombosis with a PAR1 pepducin. - Wikidata - awgldk - TriplyDB

Preventing platelet thrombosis with a PAR1 pepducin.

Preventing platelet thrombosis with a PAR1 pepducin.

http://www.wikidata.org/entity/Q37587791

about

Significance of antiplatelet therapy in emergency myocardial infarction treatment.

P2860

Q38209661-92944556-74EB-4375-9A82-3FAB4ADD6BB4

P2860

Preventing platelet thrombosis with a PAR1 pepducin.

http://www.wikidata.org/entity/Q37587791

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preventing platelet thrombosis with a PAR1 pepducin.

@en

Preventing platelet thrombosis with a PAR1 pepducin.

@nl

type

label

Preventing platelet thrombosis with a PAR1 pepducin.

@en

Preventing platelet thrombosis with a PAR1 pepducin.

@nl

prefLabel

Preventing platelet thrombosis with a PAR1 pepducin.

@en

Preventing platelet thrombosis with a PAR1 pepducin.

@nl

P1433

Q37587791-12550720-4AE7-40E8-BAAC-D0CF14DB8E0A

P1476

Q37587791-2D5B9FDA-2584-4E27-9516-41BE98268786

P2093

Q37587791-8CD256BA-CCAA-44DA-B634-8820E1D4ACC6

P2860

Q37587791-092EF33B-E800-4533-A41E-75A6A8AD8ADB

Q37587791-17F70235-DA99-455A-8CC5-E215632D13BF

Q37587791-3F5E5410-CEA7-48C5-8440-0177A48D5084

Q37587791-40F1EF11-F3E2-49DC-AEC5-AFB972997420

Q37587791-5B3996EE-E70B-4BBE-BB2D-DA80F1D78C60

Q37587791-5FC36B1F-5128-4D75-96ED-9FCFDDB26970

Q37587791-88BBDBFA-328B-4F01-A25B-A7B11375903A

Q37587791-C1748A1F-8B15-41D1-A7A1-18C11EEDC76A

Q37587791-C9F26B70-C91B-4465-A18F-89E7C8E43F40

Q37587791-CD72DA5D-EDFC-4B2E-B3BF-DA20FD80D5D0

P304

Q37587791-1F3CFF84-F7E0-4E81-9FD3-761021BB4D96

P31

Q37587791-4830f79a-0c37-41bc-abdc-6ec8a9675f34

Q37587791-93A4613E-1CCA-414B-B63C-0727D137BDD7

P356

Q37587791-89B04B03-B57F-4037-82BB-502423DED2A0

P407

Q37587791-435C7FB8-5637-468F-BF4D-9996AC9A91CD

P433

Q37587791-A4FF4FFE-71C9-44CD-8F4C-BE6979AA643D

P478

Q37587791-17DF8D34-AD61-4E30-A3A8-3EC987E273CB

P50

Q37587791-7C4C6038-8DB2-46F5-9D12-19C233FA583D

P577

Q37587791-52B9CA6A-6CC9-4CCD-BDF5-A02E6E48FE2D

P698

Q37587791-8D76AB20-72B5-4C1A-BE9D-9A62F092BFBB

P921

Q37587791-FE1808EA-8AC6-44C8-874A-DE693826F233

P932

Q37587791-C2811575-9E8D-4136-BC0E-5D4BC69AAFED

P356

CIRCULATIONAHA.112.122317

P1433

P1476

Preventing platelet thrombosis with a PAR1 pepducin.

@en

P2093

Susan S Smyth

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease.

Vorapaxar in the secondary prevention of atherothrombotic events.

Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.

Thrombin formation.

Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial.

SCH 602539, a protease-activated receptor-1 antagonist, inhibits thrombosis alone and in combination with cangrelor in a Folts model of arterial thrombosis in cynomolgus monkeys.

P304

13-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.112.122317

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P50

Ahmed Abdel-Latif

P577

2012-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22705888

http://www.w3.org/2001/XMLSchema#string

P921

P932

3926097

http://www.w3.org/2001/XMLSchema#string